Hagenimana M, Green A, Tierney J, Lenert M, Burton M
Res Sq. 2025; .
PMID: 40034446
PMC: 11875293.
DOI: 10.21203/rs.3.rs-6058617/v1.
Sleczkowska M, Almomani R, Marchi M, Salvi E, de Greef B, Sopacua M
Int J Mol Sci. 2022; 23(22).
PMID: 36430572
PMC: 9696564.
DOI: 10.3390/ijms232214095.
Zhuang L, Yu C, Xu F, Zhao L, Wang X, Wang C
Front Endocrinol (Lausanne). 2022; 13:930271.
PMID: 36082076
PMC: 9445160.
DOI: 10.3389/fendo.2022.930271.
Sleczkowska M, Almomani R, Marchi M, de Greef B, Sopacua M, Hoeijmakers J
Int J Mol Sci. 2022; 23(13).
PMID: 35806193
PMC: 9266298.
DOI: 10.3390/ijms23137190.
Lee T, Omosor E, Hussain N
Cureus. 2022; 14(1):e21193.
PMID: 35165634
PMC: 8839444.
DOI: 10.7759/cureus.21193.
Fractional Anisotropy and Troponin T Parallel Structural Nerve Damage at the Upper Extremities in a Group of Patients With Prediabetes and Type 2 Diabetes - A Study Using 3T Magnetic Resonance Neurography.
Jende J, Kender Z, Morgenstern J, Renn P, Mooshage C, Juerchott A
Front Neurosci. 2022; 15:741494.
PMID: 35140582
PMC: 8818845.
DOI: 10.3389/fnins.2021.741494.
Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross-sectional study.
Kec D, Rajdova A, Raputova J, Adamova B, Srotova I, Kralickova Nekvapilova E
Eur J Pain. 2021; 26(2):370-389.
PMID: 34592017
PMC: 9293147.
DOI: 10.1002/ejp.1865.
Roles of AMPK and Its Downstream Signals in Pain Regulation.
Wang S, Dai Y
Life (Basel). 2021; 11(8).
PMID: 34440581
PMC: 8401922.
DOI: 10.3390/life11080836.
Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy.
M S, O P
J Diabetes Metab Disord. 2021; 20(1):869-882.
PMID: 34222094
PMC: 8212194.
DOI: 10.1007/s40200-021-00734-1.
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
Sloan G, Selvarajah D, Tesfaye S
Nat Rev Endocrinol. 2021; 17(7):400-420.
PMID: 34050323
DOI: 10.1038/s41574-021-00496-z.
Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.
Ponirakis G, Abdul-Ghani M, Jayyousi A, Zirie M, Qazi M, Almuhannadi H
J Diabetes Investig. 2021; 12(9):1642-1650.
PMID: 33714226
PMC: 8409832.
DOI: 10.1111/jdi.13544.
Prevalence and Risk Factors of Sensory Symptoms in Diabetes Patients in Taiwan.
Tseng C, Chong C, Sheu J
Front Endocrinol (Lausanne). 2021; 11:580426.
PMID: 33488515
PMC: 7821276.
DOI: 10.3389/fendo.2020.580426.
Prospects for the application of transcranial magnetic stimulation in diabetic neuropathy.
Xu X, Xu D
Neural Regen Res. 2020; 16(5):955-962.
PMID: 33229735
PMC: 8178790.
DOI: 10.4103/1673-5374.297062.
Association between Sleep Quality and Painless Diabetic Peripheral Neuropathy Assessed by Current Perception Threshold in Type 2 Diabetes Mellitus.
Choi D, Kim B, Jung C, Kim C, Mok J
Diabetes Metab J. 2020; 45(3):358-367.
PMID: 32794384
PMC: 8164947.
DOI: 10.4093/dmj.2019.0219.
Polyneuropathy is inadequately treated despite increasing symptom intensity in individuals with and without diabetes (PROTECT follow-up study).
Ziegler D, Landgraf R, Lobmann R, Reiners K, Rett K, Schnell O
J Diabetes Investig. 2020; 11(5):1272-1277.
PMID: 32268450
PMC: 7477515.
DOI: 10.1111/jdi.13267.
Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
Ziegler D, Strom A, Bonhof G, Kannenberg J, Heier M, Rathmann W
BMJ Open Diabetes Res Care. 2019; 7(1):e000752.
PMID: 31803481
PMC: 6887496.
DOI: 10.1136/bmjdrc-2019-000752.
Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes.
Gylfadottir S, Christensen D, Nicolaisen S, Andersen H, Callaghan B, Itani M
Pain. 2019; 161(3):574-583.
PMID: 31693539
PMC: 7017941.
DOI: 10.1097/j.pain.0000000000001744.
Painful and non-painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues.
Gylfadottir S, Weeracharoenkul D, Andersen S, Niruthisard S, Suwanwalaikorn S, Jensen T
J Diabetes Investig. 2019; 10(5):1148-1157.
PMID: 31222961
PMC: 6717899.
DOI: 10.1111/jdi.13105.
Imbalanced oxidative stress and pro-inflammatory markers differentiate the development of diabetic neuropathy variants in streptozotocin-induced diabetic rats.
Ismail C, Abd Aziz C, Suppian R, Long I
J Diabetes Metab Disord. 2019; 17(2):129-136.
PMID: 30918846
PMC: 6405387.
DOI: 10.1007/s40200-018-0350-x.
Tanshinone IIA Attenuates Diabetic Peripheral Neuropathic Pain in Experimental Rats via Inhibiting Inflammation.
Zhang B, Yu Y, Aori G, Wang Q, Kong D, Yang W
Evid Based Complement Alternat Med. 2018; 2018:2789847.
PMID: 29713362
PMC: 5866893.
DOI: 10.1155/2018/2789847.